Drug prices The most recent policy would empower Medicare to negotiate the cost for 10 of the most expensive drugs by 2025 and 20 drugs per year by 2028. (Photo: Shutterstock)

After months of haggling, congressional Democrats on Tuesday reached a scaled-back agreement on drug pricing reform. The proposal would allow Medicare Part D to negotiate directly with pharmaceutical companies.

“It’s not everything we all want, but it’s a big step in helping the American people deal with the price of drugs,” Senate Majority Leader Chuck Schumer, D-NY, said. “Many of us would have wanted to go much further. We’ve heard from people across the country who have serious illnesses and can’t afford their medicine. Today, we’ve taken a massive step forward in helping alleviate that problem.”

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.